Business
Evolus Reports First Quarter 2025 Results
NEWPORT BEACH, Calif., May 07, 2025--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the first quarter ended March 31, 2025.
About this update from Evolus, Inc. Common Stock
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/45bd284293a1370c7045213eb82b62fe"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/AVlhK_6uNvySkNcGr4LM5Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/45bd284293a1370c7045213eb82b62fe","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/mPGEy2wiqjmYQrKn8VZY0w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/45bd284293a1370c7045213eb82b62fe","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Global Net Revenue of $68.5 Million for Q1 2025, Up 15.5% from Q1 2024","length":70,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Meaningfully Outperformed Toxin Market Share Guidance Assumptions in Slower Market","length":82,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"GAAP Operating Loss of $15.2 Million and Non-GAAP Operating Loss of $5.5 Million for the First Quarter; Remains On Track to Achieving Positive Non-GAAP Operating Income on a Consolidated Basis for the Full-Year 2025","length":215,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Evolysse™ Launched in Q2 and Off to a Strong Start","length":50,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Reaffirms 2025 Net Revenue Guidance of $345 Million to $355 Million; Evolysse™ and Estyme® Injectable Hyaluronic Acid (HA) Gels Anticipated to Contribute 8 to 10% of Total Revenue for the Full-Year 2025","length":202,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":619,"olType":false},{"type":"text","content":"NEWPORT BEACH, Calif., May 07, 2025--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the first quarter ended March 31, 2025.","length":261,"tagName":"p"},{"type":"text","content":""Coming off a record year, we enter 2025 with strong momentum," said David Moatazedi, President and Chief Executive Officer of Evolus. "In our final quarter as a single-product company, we gaine...